Multimodal therapy of cavernous sinus meningioma: Impact of surgery and 68Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome
Authors:
- Indrawati HadiIHIndrawati Hadi
- Annamaria BiczokABAnnamaria Biczok
- Nicole TerpolilliNTNicole Terpolilli
- Jun ThorsteinsdottirJTJun Thorsteinsdottir
- Robert ForbrigRFRobert Forbrig
- Barbara ZollnerBZBarbara Zollner
- Raphael BodensohnRBRaphael Bodensohn
- Stefanie CorradiniSCStefanie Corradini
- Claus BelkaCBClaus Belka
Open Access
- 20 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 3 (1) , vdab114
Abstract
Functional preservation in patients with WHO grade I meningioma involving the cavernous sinus (CSM) is crucial for long-term tumor control. Concise data on the functional outcome of an interdisciplinary, multimodal treatment are scarce. We analyzed functional outcome and tumor control in CSM patients following maximal safe resection (MSR), fractionated stereotactic radiotherapy (FSRT), or combination of them, retrospectively. Patients with WHO grade I CSM treated between 2003 and 2017 were included. Prior to FSRT, a 68Ga-DOTATATE PET/CT was performed for radiation planning. Progression-free survival (PFS) was analyzed using Kaplan–Meier method and log-rank test was performed to test differences between groups. Visual function was analyzed at baseline and follow-up. Eighty-five patients were included. MSR alone was performed in 48 patients (group A), MSR followed by FSRT in 25 patients (group B), and FSRT alone in 12 patients (group C). Intracranial tumor volumes were higher in A and B compared to C (median 9.2/10.8/4.3 ccm for A/B/C, P = .023). Median follow-up was 47/46/45 months and PFS at 5 years 55.7%, 100%, and 100% in A/B/C, respectively (P < .001). Optic nerve compression was more common in A (91.7%) and B (84.0%) than C (16.7%), P < .001. Post-therapeutic new onset or deterioration of double vision was observed in 29% (A), 17% (B), and 0% (C). Personalized treatment strategies for CSM are essential to control space-occupying or functionally compromising lesions. The additional potential side effect of radiotherapy seems to be justified under the aspect of longer tumor control with low functional risk. Without space-occupying effect of CSM, FSRT alone is reasonably possible.Keywords
This publication has 40 references indexed in Scilit:
- Does Prior Microsurgery Improve or Worsen the Outcomes of Stereotactic Radiosurgery for Cavernous Sinus Meningiomas?Neurosurgery, 2013
- Fractionated Conformal Radiotherapy in the Management of Cavernous Sinus Meningiomas: Long-Term Functional Outcome and Tumor Control at a Single InstitutionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Fractionated Stereotactic Radiotherapy Treatment of Cavernous Sinus Meningiomas: A Study of 100 CasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Management options for cavernous sinus meningiomasJournal of Neuro-Oncology, 2009
- Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment aloneJournal of Neurosurgery, 2007
- Fractionated Stereotactic Radiation Therapy in the Management of Benign Cavernous Sinus MeningiomasStrahlentherapie und Onkologie, 2006
- Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and toleranceSurgical Neurology, 2006
- Long-term Tumor Control and Functional Outcome in Patients with Cavernous Sinus Meningiomas Treated by Radiotherapy with or without Previous Surgery: Is There an Alternative to Aggressive Tumor Removal?Neurosurgery, 2001
- Long-term Follow-up of Patients with Meningiomas Involving the Cavernous Sinus: Recurrence, Progression, and Quality of LifeNeurosurgery, 1996
- Outcome of aggressive removal of cavernous sinus meningiomasJournal of Neurosurgery, 1994